trixomash 1 gm vial

TRIXOMASH is a broad-spectrum antibiotic used to treat severe bacterial infections by inhibiting bacterial cell wall synthesis, thereby preventing bacterial growth and eliminating susceptible microorganisms.

It is effective in the treatment of serious infections affecting the respiratory tract, urinary tract, bloodstream, bones, joints, skin, and soft tissues. TRIXOMASH is also widely used for surgical prophylaxis to reduce the risk of postoperative bacterial infections.

TRIXOMASH Active Ingredient

• Ceftriaxone.

TRIXOMASH Strengths

• 1 g vial for intravenous (I.V.) injection.

• 1 g vial for intramuscular (I.M.) injection.

• 500 mg vial for intramuscular (I.M.) injection.

• 500 mg vial for intravenous (I.V.) injection.

TRIXOMASH Uses

• Treatment of acute bacterial pneumonia and other lower respiratory tract infections.

• Treatment of pyelonephritis and complicated urinary tract infections.

• Management of severe infections of the bones, joints, skin, and soft tissues.

• Treatment of bacterial septicemia and acute bacterial meningitis.

• Prevention of bacterial infections before and after major surgical procedures.

TRIXOMASH Dosage

The dosage depends on the type and severity of the infection as well as the patient's clinical condition. The usual adult dose is 1–2 g daily, administered either intravenously or intramuscularly according to the physician's assessment.

Pediatric and infant doses are calculated individually based on body weight, age, and the type of infection. Follow the prescribed dosage and complete the full course of treatment without interruption unless instructed otherwise by your physician.

TRIXOMASH Side Effects

• Mild pain, redness, or irritation at the injection site.

• Mild gastrointestinal disturbances such as temporary diarrhea or nausea.

• Temporary changes in laboratory test results, including liver enzymes or blood cell counts, which usually resolve after treatment is completed.

TRIXOMASH Contraindications

• Do not use this medication in patients with a history of hypersensitivity or severe allergic reactions to ceftriaxone or other cephalosporin antibiotics.

• It should also be avoided in patients with severe penicillin allergy because of the risk of cross-reactivity.

• Ceftriaxone is contraindicated in hyperbilirubinemic neonates and premature infants, as well as in neonates receiving intravenous calcium-containing solutions due to the risk of calcium-ceftriaxone precipitation in the lungs and kidneys.

TRIXOMASH Alternatives

• Ceftriaxone.

• Wintriaxone.

• Trixamarc.

• Cefotrix.

Use During Pregnancy and Breastfeeding

TRIXOMASH may be used during pregnancy if the treating physician determines that the expected benefits outweigh the potential risks. Treatment should always be administered under appropriate medical supervision.

Small amounts of ceftriaxone may pass into breast milk. Therefore, breastfeeding mothers should consult their physician before using this medication to determine whether it is appropriate while ensuring the infant's safety. Always follow the prescribed dosage and duration of treatment.

Storage Conditions

• Store the dry powder in a cool, dry place at a temperature not exceeding 25°C.

• Keep the vial in its original carton to protect it from moisture and direct sunlight.

• Store out of the sight and reach of children.